中牧股份(600195.SH):擬分拆乾元浩至上交所科創板上市
格隆匯 12 月 3日丨中牧股份(600195.SH)公佈,中牧股份擬將其子公司乾元浩分拆至上交所科創板上市。此次分拆完成後,中牧股份股權結構不會發生變化且仍擁有對乾元浩的控股權。
通過此次分拆,中牧股份將進一步實現業務聚焦,更加專注於畜用疫苗、獸用化藥、飼料及飼料添加劑、貿易業務;乾元浩將依託上交所科創板平台獨立融資,通過上市進一步促進禽用生物製品的研發、生產和銷售業務的發展。本次分拆將進一步增強公司及所屬子公司的盈利能力和綜合競爭力,並促使公司取得合理市場估值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.